Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$97,441,701
+$38,070,548 QoQ
Shares Held
81,240
+25.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#387
of 4,621 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$32,624,498
CallShares
27,200
PutValue
$27,946,721
PutShares
23,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. LLY ranks #3 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,085,383 | $581,119,768 | |
| 2 | AMGN |
Amgen Inc
|
1,128,681 | $408,717,963 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
81,240 | $97,441,701 | |
| 4 | AZN |
Astrazeneca PLC
|
329,087 | $62,401,476 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
409,174 | $51,695,043 | |
| 6 | ABBV |
AbbVie Inc.
|
198,249 | $49,887,378 | |
| 7 | JNJ |
Johnson & Johnson
|
34,909 | $8,865,838 | |
| 8 | PFE |
Pfizer Inc
|
330,300 | $7,953,624 |
All Filings in LLY
Export CSV
36 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,624,498 | 27,200 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $97,441,701 | 81,240 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $27,946,721 | 23,300 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $3,403,149 | 3,700 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $4,598,850 | 5,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $59,371,153 | 64,550 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,224,040 | 3,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $14,043,919 | 13,068 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,526,000 | 2,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $153,291,278 | 200,906 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $57,489,557 | 73,749 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,994,042 | 15,733 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $249,116,680 | 322,690 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $176,954,111 | 199,736 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $204,416,696 | 225,780 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,718,273 | 71,621 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $57,823,332 | 99,196 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $232,434,413 | 432,734 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $107,667,443 | 294,302 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $126,213,568 | 440,736 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $112,261,056 | 406,419 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $2,762,200 | 10,000 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $2,872,688 | 10,400 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $230,336,055 | 996,910 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $947,305 | 4,100 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $693,150 | 3,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $2,364,056 | 10,300 | Put | Sole | 2021-08-16 | |
| 2021-06-30 | $1,859,112 | 8,100 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $784,644 | 4,200 | Put | Sole | 2021-05-17 | |
| 2020-12-31 | $506,520 | 3,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $1,215,648 | 7,200 | Put | Sole | 2021-02-16 | |
| 2020-09-30 | $19,274,128 | 130,213 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $328,360 | 2,000 | Put | Sole | 2020-08-14 | |
| 2020-06-30 | $974,900 | 5,938 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $68,969,364 | 497,184 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $624,240 | 4,500 | Put | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||